EREG

epiregulin

Epiregulin; EPR; EREG; ER; Ereg; epiregulin; proepiregulin;

NRF1

nuclear respiratory factor 1

NRF1; nuclear respiratory factor 1; alpha palindromic binding protein; ALPHA PAL; EWG; NRF-1; alpha palindromic-binding protein; ALPHA-PAL;

PIR

pirin (iron-binding nuclear protein)

PIR; pirin (iron-binding nuclear protein); pirin; Iron binding nuclear protein; OTTHUMP00000022961; OTTHUMP00000022962; probable quercetinase; probable quercetin 2,3-dioxygenase PIR;

SPIRE1

spire homolog 1 (Drosophila)

SPIRE1; spire homolog 1 (Drosophila); protein spire homolog 1; KIAA1135; spir 1; MGC150621; MGC150622; Spir1; SPIRE 1; Spire homolog 1; Spir-1;

EMX2

empty spiracles homeobox 2

EMX2; empty spiracles homeobox 2; empty spiracles homolog 2 (Drosophila); homeobox protein EMX2; empty spiracles homolog 2; empty spiracles-like protein 2;

RSV

Respiratory Syncytial Virus

RSV; Respiratory Syncytial Virus;

EMX1

empty spiracles homeobox 1

EMX1; empty spiracles homeobox 1; homeobox protein EMX1; empty spiracles homolog 1; empty spiracles-like protein 1;

OTOS

otospiralin

OTOS; otospiralin; OTOSP; OTOSP_HUMAN;

SPIRE2

spire homolog 2 (Drosophila)

SPIRE2; spire homolog 2 (Drosophila); protein spire homolog 2; KIAA1832; spir 2; MGC117166; Spir-2; SPIR2_HUMAN;

RSV?protein F

Fusion protein (F) [Respiratory syncytial virus]

RSV; F; Fusion protein (F); NP_044596.1; UniProt ID: O09720; O09720; Entrez: 1494475; Entrez Gene: 1494475; Gene ID: 1494475; Palivizumab; Synagis ; Palivizumab; Synagis;

Biomolecular Finding: New Toxic-antitoxic System May Help to Inspire New Antibiotics

The picture shows DnaN in complex with a peptide from DNA polymerase III. The toxin SocB likely disrupts this complex to arrest DNA replication by binding a region of DnaN near the residue marked in green. One of the reasons leading to trick...

Biosimilar Market in India: the Approaching of the Expiration of Herceptin Patent in India

Roches patent on Herceptin will soon expire in India, thus today here we briefly talk about the biosimilar market in India regarding this. According to authority information, there is still no clear trend if the local pharmaceuticals start to march to biosimilar market. ...